HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC VAGINAL DRUG PRODUCT MONOGRAPH PROPOSAL WITHDRAWN BY FDA

This article was originally published in The Rose Sheet

Executive Summary

OTC VAGINAL DRUG PRODUCT MONOGRAPH PROPOSAL WITHDRAWN BY FDA in a notice published in the Feb. 3 Federal Register. The agency said it has decided to withdraw an October 1983 advance notice of proposed rulemaking that would have been the basis for a monograph covering over-the-counter vaginal drug products after determining that "some of the recommended labeling indications and ingredients used for minor irritation, itching or soreness are not unique to the vaginal area and are already being considered" in other OTC rulemakings.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

RS000130

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel